Clinicopathological significance of sentinel node biopsy in Japanese patients with cutaneous malignant melanoma

Journal of Dermatology

Volumn 38, Issue 1, 2011, Pages 76-83

  Noro, Sachiko ^a,b   Yamazaki, Naoya ^b   Nakanishi, Yukihiro ^c   Yamamoto, Akifumi ^d   Sasajima, Yuko ^e   Kawana, Seiji ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b Department of Dermatology ^*  (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

^d SAITAMA MEDICAL UNIVERSITY   (Japan)

^e SAINT LOUIS UNIVERSITY   (United States)

Author keywords

clinicopathological study; Japanese patients; malignant melanoma; metastasis; sentinel lymph node

Indexed keywords

COLLOID TC 99M;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; JAPANESE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; PATHOLOGY; SCHOOL CHILD; SENTINEL LYMPH NODE BIOPSY; SURVIVAL RATE; THICKNESS; TUMOR CELL; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; PROGNOSIS; S100 PROTEINS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; YOUNG ADULT;

EID: 78650681380     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2010.01002.x     Document Type: Article

References (24)

1. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-399.
2. Krag DN, Weaver DL, Alex JC, Fairbank JT,. Surgical resection and radiolocalization of sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993; 2: 335-339.
3. Cochran AJ, Roberts AA, Saida T,. The place of lymphatic mapping and sentinel node biopsy in oncology. Int J Clin Oncol 2003; 8: 139-150.
4. Noro S, Yamamoto A, Yamazaki N, et al. Sentinel lymph node biopsy and pathological examination for malignant melanoma in the dermatology division of National Caner Center Hospital. Jpn J Dermatol 2004; 114: 15-24 (In Japanese).
5. McMasters KM, Reintgen DS, Ross MI, et al. Sentinel Lymph node biopsy for melanoma: how many radioactive nodes should be removed? Ann Surg Oncol 2001; 8: 192-197.
6. Dorvault CC, Weilbaecher KN, Yee H, et al. Microphthalmia transcription factor. Cancer 2001; 93: 337-343.
7. King R, Weilbaecher KN, McGill G, Cooley E, Mihm M, Fisher DE,. Microphthalmia transcription factor. A sensitive and specific melanocyte marker for melanoma diagnosis. Am J Pathol 1999; 155: 731-738.
8. King R, Googe PB, Weilbaecher KN, Mihm MC Jr, Fisher DE,. Microphthalmia transcription factor expression in cutaneous benign, malignant melanocytic,and nonmelanocytic tumors. Am J Surg Pathol 2001; 25: 51-57.
9. Granter SR, Weilbaecher KN, Quigley C, Fletcher CD, Fisher DE,. Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma. Am J Dermatopathol 2001; 23: 185-189.
10. Chang KL, Folpe AL,. Diagnostic utility of microphthalmia transcription factor in malignant melanoma and other tumors. Adv Anat Pathol 2001; 8: 273-275.
11. Miettinen M, Fernandez M, Franssila K, Gatalica Z, Lasota Z, Sarlomo-Rikala M,. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers. Am J Surg Pathol 2001; 25: 205-211.
12. Busam KJ, Jungbluth AA,. Melan-A, a new melanocytic differentiation marker. Adv Anat Pathol 1999; 6: 12-18.
13. Busam KJ, Chen YT, Old LJ, et al. Expression of Melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma. Am J Surg Pathol 1998; 22: 976-982.
14. Baisden BL, Askin FB, Lange JR, Westra WH,. HMB-45 immunohistochemical staining of sentinel lymph nodes: a specific method for enhancing detection of micrometastases in patients with melanoma. Am J Surg Pathol 2000; 24 (8): 1140-1146.
15. Yu LL, Flotte TJ, Tanabe KK, et al. Detection of microscopic melanoma metastases in sentinel lymph nodes. Cancer 1999; 86: 617-627.
16. Cochran AJ, Balda BR, Starz H, et al. The Augsburg Consensus. Techniques of lymphatic mapping, sentinel lymphadenectomy and completion lymphadenectomy in cutaneous malignancies. Cancer 2000; 89: 236-241.
17. Sobin LH, Wittekind CH,. Skin tumors, malignant melanoma of skin. In: International Union Against Cancer (UICC): TNM Classification of Malignant Tumors, 6th edn. New York: Wiley-Liss, 2002; 126-130.
18. Ross GL, Shoaib T, Scott J, et al. The impact of immunohistochemistry on sentinel node biopsy for primary cutaneous malignant melanoma. Br J Plast Surg 2003; 56: 153-155.
19. Lingam MK, Mackie RM, McKay AJ,. Intraoperative identification of sentinel lymph node in patients with malignant melanoma. Br J Cancer 1997; 75: 1505-1508.
20. Gogel BM, Kuhn JA, Ferry KM, et al. Sentinel lymph node biopsy for melanoma. Am J Surg 1998; 176: 544-547.
21. Statius Muller MG, Borgstein PJ, Pijpers R, et al. Reliability of the sentinel node procedure in melanoma patients: analysis of failures after long-term follow-up. Ann Surg Oncol 2000; 7: 461-468.
22. Clary BM, Brady MS, Lewis JJ, Coit DG,. Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence. Ann Surg 2001; 233: 250-258.
23. Harlow SP, Krag DN, Ashikaga T, et al. Gamma probe guided biopsy of the sentinel node in malignant melanoma: a multicentre study. Melanoma Res 2001; 11: 45-55.
24. Li LX, Scolyer RA, Ka VS, et al. Pathologic review of negative sentinel lymph nodes in melanoma patients with regional recurrence: a clinicopathologic study of 1152 patients undergoing sentinel lymph node biopsy. Am J Surg Pathol 2003; 27: 1192-1202.